ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,226Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 917

$729K Total Retail Price of All Prescriptions

Rank: 37 out of 917

479 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 15,884 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 1,543 1,506 1 5
ALENDRONATE SODIUM 808 808 2 23
METFORMIN HCL 806 800 3 8
OMEPRAZOLE 752 738 4 4
LOVASTATIN 716 704 5 19
MELOXICAM 617 600 6 53
LIDODERM 520 520 7 64
CREON 396 394 8 156
DIOVAN HCT 364 364 9 118
LOSARTAN POTASSIUM 362 342 10 13
LISINOPRIL 318 298 11 1
TAMSULOSIN HCL 314 299 12 25
SIMVASTATIN 305 301 13 2
METOPROLOL SUCCINATE 301 292 14 18
LOSARTAN-HYDROCHLOROTHIAZIDE 301 301 14 62
FINASTERIDE 274 264 16 77
PRAVASTATIN SODIUM 242 240 17 20
NEXIUM 226 226 18 60
VOLTAREN 216 216 19 149
ATENOLOL-CHLORTHALIDONE 203 203 20 242
GLIMEPIRIDE 202 191 21 54
ATENOLOL 195 189 22 12
PENTOXIFYLLINE 187 187 23 251
ATORVASTATIN CALCIUM 172 167 24 14
METOPROLOL TARTRATE 171 159 25 11
DIOVAN 171 171 25 49
CLOTRIMAZOLE-BETAMETHASONE 165 164 27 161
EVISTA 158 152 28 130
FLUOCINONIDE 153 153 29 264
GLIPIZIDE 137 132 30 40
DONEPEZIL HCL 132 132 31 32
RANITIDINE HCL 132 132 31 29
HYDROCHLOROTHIAZIDE 127 123 33 9
PROCTOZONE-HC 122 110 34 250
JANUVIA 119 117 35 81
FLUTICASONE PROPIONATE 117 116 36 26
AZITHROMYCIN 116 116 37 61
LEVOTHYROXINE SODIUM 116 113 37 3
LIPITOR 113 113 39 89
CIPROFLOXACIN HCL 105 105 40 72
MEGESTROL ACETATE 104 104 R 41 196
CLOBETASOL PROPIONATE 92 80 42 203
LEVOFLOXACIN 92 92 42 138
FUROSEMIDE 91 91 44 7
TRIAMTERENE-HCTZ 88 81 45 36
GEMFIBROZIL 86 86 46 140
ADVAIR DISKUS 86 86 46 47
POTASSIUM CHLORIDE 82 82 48 16
SUCRALFATE 78 78 49 211
CLOPIDOGREL 76 76 50 50
ACTOS 74 74 51 112
GLIPIZIDE ER 73 71 52 128
TERAZOSIN HCL 71 71 53 108
WARFARIN SODIUM 66 66 54 10
GLYBURIDE MICRONIZED 62 62 R 55 357
PROAIR HFA 60 60 56 35
ZOLPIDEM TARTRATE 55 51 57 21
CEPHALEXIN 54 52 58 105
PREDNISONE 52 51 59 34
LANSOPRAZOLE 52 52 59 259
ACTONEL 52 52 59 278
DETROL LA 51 51 62 243
CRESTOR 50 50 63 30
BENICAR 50 50 63 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 14, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.